Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

The Transcriptome of Estrogen-Independent Mammary Growth in Female Mice Reveals That Not All Mammary Glands Are Created Equally.

Berryhill GE, Lemay DG, Trott JF, Aimo L, Lock AL, Hovey RC.

Endocrinology. 2017 Oct 1;158(10):3126-3139. doi: 10.1210/en.2017-00395.

PMID:
28938404
2.

Prognostic Value of Clinicopathological Factors for Indonesian Breast Carcinomas of Different Molecular Subtypes

Widodo I, Dwianingsih EK, Anwar SL, Fx Ediati T, Utoro T, Aryandono T, Soeripto.

Asian Pac J Cancer Prev. 2017 May 1;18(5):1251-1256.

3.

Applying nanomedicine in maladaptive inflammation and angiogenesis.

Alaarg A, Pérez-Medina C, Metselaar JM, Nahrendorf M, Fayad ZA, Storm G, Mulder WJM.

Adv Drug Deliv Rev. 2017 Sep 15;119:143-158. doi: 10.1016/j.addr.2017.05.009. Epub 2017 May 12. Review.

PMID:
28506745
4.

Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1.

Cohen N, Shani O, Raz Y, Sharon Y, Hoffman D, Abramovitz L, Erez N.

Oncogene. 2017 Aug;36(31):4457-4468. doi: 10.1038/onc.2017.65. Epub 2017 Apr 3.

5.

Interferon signaling in ascites-associated macrophages is linked to a favorable clinical outcome in a subgroup of ovarian carcinoma patients.

Adhikary T, Wortmann A, Finkernagel F, Lieber S, Nist A, Stiewe T, Wagner U, Müller-Brüsselbach S, Reinartz S, Müller R.

BMC Genomics. 2017 Mar 21;18(1):243. doi: 10.1186/s12864-017-3630-9.

6.

Self-renewal and phenotypic conversion are the main physiological responses of macrophages to the endogenous estrogen surge.

Pepe G, Braga D, Renzi TA, Villa A, Bolego C, D'Avila F, Barlassina C, Maggi A, Locati M, Vegeto E.

Sci Rep. 2017 Mar 20;7:44270. doi: 10.1038/srep44270.

7.

The Unique Molecular and Cellular Microenvironment of Ovarian Cancer.

Worzfeld T, Pogge von Strandmann E, Huber M, Adhikary T, Wagner U, Reinartz S, Müller R.

Front Oncol. 2017 Feb 22;7:24. doi: 10.3389/fonc.2017.00024. eCollection 2017. Review.

8.

Tumour-associated macrophages as treatment targets in oncology.

Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P.

Nat Rev Clin Oncol. 2017 Jul;14(7):399-416. doi: 10.1038/nrclinonc.2016.217. Epub 2017 Jan 24. Review.

PMID:
28117416
9.

One microenvironment does not fit all: heterogeneity beyond cancer cells.

Kim IS, Zhang XH.

Cancer Metastasis Rev. 2016 Dec;35(4):601-629. doi: 10.1007/s10555-016-9643-z. Review.

PMID:
27858305
10.

Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast.

Campbell MJ, Baehner F, O'Meara T, Ojukwu E, Han B, Mukhtar R, Tandon V, Endicott M, Zhu Z, Wong J, Krings G, Au A, Gray JW, Esserman L.

Breast Cancer Res Treat. 2017 Jan;161(1):17-28. doi: 10.1007/s10549-016-4036-0. Epub 2016 Oct 26.

PMID:
27785654
11.

The transcriptional signature of human ovarian carcinoma macrophages is associated with extracellular matrix reorganization.

Finkernagel F, Reinartz S, Lieber S, Adhikary T, Wortmann A, Hoffmann N, Bieringer T, Nist A, Stiewe T, Jansen JM, Wagner U, Müller-Brüsselbach S, Müller R.

Oncotarget. 2016 Nov 15;7(46):75339-75352. doi: 10.18632/oncotarget.12180.

12.

Macrophage Densities Correlated with CXC Chemokine Receptor 4 Expression and Related with Poor Survival in Anaplastic Thyroid Cancer.

Kim DI, Kim E, Kim YA, Cho SW, Lim JA, Park YJ.

Endocrinol Metab (Seoul). 2016 Sep;31(3):469-475. doi: 10.3803/EnM.2016.31.3.469. Epub 2016 Aug 2.

13.

Tumour sampling method can significantly influence gene expression profiles derived from neoadjuvant window studies.

Pearce DA, Arthur LM, Turnbull AK, Renshaw L, Sabine VS, Thomas JS, Bartlett JM, Dixon JM, Sims AH.

Sci Rep. 2016 Jul 7;6:29434. doi: 10.1038/srep29434.

14.

Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians.

Koru-Sengul T, Santander AM, Miao F, Sanchez LG, Jorda M, Glück S, Ince TA, Nadji M, Chen Z, Penichet ML, Cleary MP, Torroella-Kouri M.

Breast Cancer Res Treat. 2016 Jul;158(1):113-26. doi: 10.1007/s10549-016-3847-3. Epub 2016 Jun 9.

15.

The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis.

Mao Y, Qu Q, Chen X, Huang O, Wu J, Shen K.

PLoS One. 2016 Apr 13;11(4):e0152500. doi: 10.1371/journal.pone.0152500. eCollection 2016. Review.

16.

Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy.

Williams CB, Yeh ES, Soloff AC.

NPJ Breast Cancer. 2016;2. pii: 15025. Epub 2016 Jan 20.

17.
18.

Macrophages: Regulators of the Inflammatory Microenvironment during Mammary Gland Development and Breast Cancer.

Brady NJ, Chuntova P, Schwertfeger KL.

Mediators Inflamm. 2016;2016:4549676. doi: 10.1155/2016/4549676. Epub 2016 Jan 17. Review.

19.

Family History of Cancer in Relation to Breast Cancer Subtypes in African American Women.

Bethea TN, Rosenberg L, Castro-Webb N, Lunetta KL, Sucheston-Campbell LE, Ruiz-Narváez EA, Charlot M, Park SY, Bandera EV, Troester MA, Ambrosone CB, Palmer JR.

Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):366-73. doi: 10.1158/1055-9965.EPI-15-1068. Epub 2015 Dec 31.

20.

Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity.

Dahlberg CI, Sarhan D, Chrobok M, Duru AD, Alici E.

Front Immunol. 2015 Nov 30;6:605. doi: 10.3389/fimmu.2015.00605. eCollection 2015. Review.

Supplemental Content

Support Center